|Description||Purmorphamine, under the IUPAC name 9-Cyclohexyl-N-[4-(4-morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine, is a cell-permeable 6,9-trisubstituted purine which directly binds and activates Smoothened (in HEK293T cell：IC50= ~ 1.5 μM ).So it has been shown to activate the Hedgehog (Hh) signaling pathway which is important for regulating embryonic patterning, stem cell renewal, and tissue regeneration. In vitro: An activator of the hedgehog (Hh) signaling pathway by directly binds and activates Smoothened (in HEK293T cell：IC50= ~ 1.5 μM ). In vivo: Purmorphamine up-regulates ALP expression in human mesenchymal stem cell-based constructs on rats.|
|B0084-211514||100 mg||$299||In stock|
|Appearance||Pale beige solid|
|Synonyms||9-cyclohexyl-N-(4-morpholin-4-ylphenyl)-2-naphthalen-1-yloxypurin-6-amine; purmorphamine; Purmorphamine; 483367-10-8; 2-(1-Naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; UNII-PB12M2F8KY; Shh Signaling Antagonist VI; PB12M2F8KY; CHEMBL1221984; CHEBI:63053; C31H32N6O2; IN1132; 9-cyclohexyl-N-[4-(morpholin-4-yl)phenyl]-2-(naphthalen-1-yloxy)-9H-purin-6-amine; 9-cyclohexyl-N-(4-morpholin-4-ylphenyl)-2-naphthalen-1-yloxypurin-6-amine; 9-Cyclohexyl-N-[4-(4-morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine; 9-Cyclohexyl-N-(4-(4-morpholinyl)phenyl)-2-(1-naphthalenyloxy)-9H-purin-6-amine; Purmorphamine [MI]; MolMap_000073; AC1NR49A; MLS006010334; SCHEMBL1548273; CTK1D4950; AOB5391; DTXSID20415293; FYBHCRQFSFYWPY-UHFFFAOYSA-N; HMS3650O20; BDBM50324671; HSCI1_000224; IN2207; NSC747596; ZINC14806830; AKOS024458218; 2- -6- -9-CYCLOHEXYLPURINE; CS-1135; LS41103; NSC-747596; RL03799; NCGC00344053-01; 4CA-1056; AK175828; BC600598; DA-05531; HE070984; HE345035; HY-15108; KB-80166; QC-10453; SMR004701397; AB0032036; X5299; Purmorphamine and Shh Signaling Antagonist VI; W-5393; BRD-K73397362-001-01-7; 2-(1-Napthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; 9-cyclohexyl-N-(4-morpholinophenyl)-2-(naphthalen-1-yloxy)-9H-purin-6-amine; 9-Cyclohexyl-N-[4-(morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine; 9H-Purin-6-amine, 9-cyclohexyl-N-(4-(4-morpholinyl)phenyl)-2-(1-naphthalenyloxy)-; 9-?CYCLOHEXYL-?N-?[4-?(MORPHOLINYL)PHENYL]-?2-?(1-?NAPHTHALENYLOXY)-?9H-?PURIN-?6-?AMINE|
|Application||Directly binds and activates Smoothened (in HEK293T cell：IC50= ~ 1.5 μM ); An activator of the hedgehog (Hh) signaling pathway; An inducer of osteoblast differentiation (EC50= 1 μM)|
|Quality Standard||In-house standard|
SAG is a potent and cell-permeable Smoothened (Smo) receptor agonist that regulates hedgehog signaling. SAG inhibits hedgehog signaling at high concentrations.
Glasdegib, als known as PF-04449913, is an orally bioavailable small-molecule inhibitor of the Hedgehog (Hh) signaling pathway with potential antineoplastic act...
M 25 is a potent Smoothened (Smo) receptor antagonist with IC50 value of 5 nM. It inhibits the Hedgehog signaling pathway. It also inhibits Shh induced Gli luci...
SANT-2 is an inhibitor of Sonic hedgehog (Shh) signaling and an antagonist of smoothened receptor activity (KD = 12 nM). SANT-2 exhibits smo-[3H]SAG-1.3 and -[3...
SAG is a potent Smoothened (Smo) receptor agonist (Kd = 59 nM); sag antagonizes cyclopamine action at the Smo receptor.
BMS-833923, also known as XL-139, is an orally bioavailable small-molecule SMO (Smoothened) inhibitor with potential antineoplastic activity. SMO antagonist BMS...
Cyclopamine (11-deoxojervine) is a naturally occurring chemical that belongs to the group of steroidal jerveratrum alkaloids. It is a teratogen isolated from th...
SMANT hydrochloride is an inhibitor of Smoothened (Smo) signaling via a unique mechanism. SMANT inhibits both wild-type Smo and an oncogenic form (SmoM2) with s...
This active molecular is a Smoothened (Smo) antagonist with potential antitumor activity. LEQ506 selectively binds to the Hedgehog（Hh） ligand cell surface recep...
This active molecular is a novel potent Smoothened antagonist. MRT-83 blocks Hedgehog (Hh) signaling in various assays and IC50 can be in nmol range, showing gr...
IHR-Cy3 is a potent fluorescent Smo antagonist with IC50 value of 100 nM.
Taladegib binds to the Smoothened (Smo) receptor and potently inhibits Hedgehog (Hh) signaling.
MRT-92 HCl salt
MRT-92 is a selective Smoothened (Smo) receptor inhibitor. It shows subnanomolar antagonist activity against Smo in various Hh cell-based assays. MRT-92 inhibit...
IHR 1 is a potent and cell-membrane-impermeable Smo antagonist with IC50 value of 7.6 nM. It blocks hedgehog induced movement of Smo and blocks Smo accumulation...
Sonidegib, also known as, erismodegib (LDE225, NVP-LDE225) is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic ac...
MRT 10 is a smoothened (Smo) receptor antagonist (IC50 = 0.5 μM in HEK293 cells transiently expressing mouse Smo). It also inhibits bodipy-cyclopamine binding t...
PF 5274857 hydrochloride
PF 5274857 hydrochloride is a high affinity and selective Smoothened (Smo) receptor antagonist (Ki = 4.6 nM), with >1000-fold selectivity for Smo over a panel o...
MK-4101 is a potent and selective SMO Inhibitor of the Hedgehog Pathway with anti-tumor activity. MK-4101 targets the Hh pathway in tumor cells, showing the max...
Purmorphamine, under the IUPAC name 9-Cyclohexyl-N-[4-(4-morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine, is a cell-permeable 6,9-trisubstituted pur...
PF-5274857 is a potent and selective Smoothened (Smo) antagonist, inhibits Hedgehog (Hh) signaling with IC50 and Ki of 5.8 nM and 4.6 nM, respectively, and can ...